STEGLUJAN 5 mg/1

Steglujan 5 mg/1 combines ertugliflozin and sitagliptin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Steglujan 5 mg/1 is used to help manage type 2 diabetes in adults. This combination medication works by improving insulin sensitivity and reducing glucose absorption in the kidneys. It is typically prescribed alongside diet and exercise to support overall blood sugar management.

Common effects of Steglujan 5 mg/1 may include urinary tract infections, hypoglycemia, and gastrointestinal discomfort. Some users may also experience increased urination or dizziness. These effects vary and are not experienced by everyone.

Steglujan 5 mg/1 should be used with caution in individuals with kidney issues or a history of pancreatitis. It is important to stay hydrated and monitor blood sugar levels regularly. Always follow the advice of a healthcare provider regarding its use.

Steglujan 5 mg/1 may interact with other medications, including insulin, beta-blockers, and certain antibiotics. Alcohol consumption should be limited, as it can affect blood sugar levels. Always inform your healthcare provider about all medications you are taking.